Clorox shareholders elected the consumer-products company’s 10 director nominees and approved an advisory executive-compensation resolution at a Nov. 18 virtual annual meeting, according to a Securities and Exchange Commission filing.
The elected directors are Gina Boswell, Stephen B. Bratspies, Pierre R. Breber, Julia Denman, Esther Lee, Stephanie Plaines, Linda Rendle, Matthew J. Shattock, Russell J. Weiner and Christopher J. Williams.
Support for the nominees ranged from 75,820,960 votes for Lee to 77,420,821 for Bratspies. Each director vote included 23,687,874 broker non-votes, which are shares held in brokerage accounts that were not voted on the item.
The named executive officer compensation measure passed on an advisory basis, meaning it records shareholder views rather than creating a binding pay decision. The resolution received 72,129,289 votes for, 5,853,814 against and 452,207 abstentions, alongside 23,687,874 broker non-votes.
Shareholders also approved Ernst & Young LLP as Clorox’s independent auditor for the fiscal year ending June 30, 2027. That resolution drew 98,404,758 votes for, 3,474,668 against and 243,758 abstentions, with no broker non-votes.
Clorox’s common stock has a $1 par value and trades on the New York Stock Exchange under the ticker CLX. The filing did not provide shareholder-turnout figures or a market reaction to the meeting.



